How the FDA Panel’s Votes on Avandia Votes Went Down


Published On: July 15th, 2010

On the final vote, most panelists recommended Avandia stay on the market but have more label warnings or a restricted use.

Excerpt from:
How the FDA Panel’s Votes on Avandia Votes Went Down



Loading...


Comments are closed.